UFP Technologies, Inc. · NASDAQ:UFPT
UFP Technologies — Investor Presentation (August 2020)
31 slides from UFP Technologies's investor presentation, Aug 25, 2020

Slide 1: Welcome Investors August 2020
Welcome Investors August 2020

Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains forward - looking information that involves risks and uncertainties, including statements about the Company’s prospects, anticipated advantages the Company expects to realize from its acquisition strategies, the Company’s financial performance, target

Slide 3: Who We Are
Who We Are UFP Technologies is an innovative designer and custom manufacturer of components, subassemblies, products and packaging primarily for the medical market. Key Stats: Headquarters: Newburyport, MA Ticker: UFPT Market Cap: $335 million 1 Share Count: 7.5 million 2019 Annual Revenue: $198.8 m

Slide 4: Shaping Innovation
Shaping Innovation We help our customers develop, improve, manufacture, or safely transport their products through : Materials expertise Design engineering capabilities Precision manufacturing capabilities

Slide 5: Our Process
Our Process Innovative process from design and engineering to manufacturing and delivery C u s t omer C h alle n g e Design & D e v elo p me n t Pro t o t y p e Tooli n g Custom E qu i p me n t Quality S ys t ems C ommer c ial Production Pilot M a nuf a c t u r i n g Proprietary and Tested Technolog

Slide 6: Product Development Business Benefits
Product Development Business Benefits High Margin Added Expertise Stronger Customer Relationships Long Term Manufacturing

Slide 7: Growth Strategy Two-Pronged
Growth Strategy Two - Pronged 1. Internal Growth: Market To Our Sweet Spot 2. Strategic Acquisitions

Slide 8: Primary Focus Areas
65% 10% 9% 4% 5% 7% Primary Focus Areas Medical • Infection prevention • Minimally Invasive Surgery • Fluid & Air Management • Protective Packaging • Patient Comfort • Wound Care • Wearables Automotive • Interior Trim & Structural • Acoustic/Thermal Insulation C onsum e r • Foam and fiber packaging

Slide 9: MedTech
M e d T e c h $457 billion Global Medical Device Market with a 4.4% CAGR 1 • UFP expertise in component solutions for orthopedics, infection prevention, wound care, and minimally invasive surgery • Customers include 24 of the top 28 largest medical device manufacturers in the world 2 UFP Differentia

Slide 10: MedTech Product Portfolio
MedTech Product Portfolio Implant Packaging Radial Compression Device Equipment Drapes MedSurg Bed Compression Device Negative Pressure Wound Therapy (NPWT) Needleless Injection Cap Cleaners Surgical Site Prep

Slide 11: Advanced Components
Advanced Components Automotive Aerospace & Defense Consumer • Highly engineered components and packaging used in targeted large and growing niches • Our products are present on many of the world’s leading brands including GM, Ford, Mercedes, Boeing, Lockheed Martin, Bath & Body Works, Philips, Dell,

Slide 12: Advanced Components Product Portfolio
Advanced Components Product Portfolio Military Uniform Gear Protective Cases SUV Load Floors Automotive Interior Trim Lacrosse Helmet Comfort Padding Candle Protective Packaging

Slide 13: Why Invest?
Why Invest? • Significant market growth opportunities • Barriers to entry • Strong customer relationships • Experienced management team • Proven growth strategy • Attractive financial metrics

Slide 14: Why is UFP an Exciting Investment?
Why is UFP an Exciting Investment? Significant market growth opportunities • Addressable market is growing ▪ Medical device development ▪ Medical device manufacturing ▪ Medical components ▪ Medical packaging • Universe of specialty materials growing

Slide 15: Barriers To Entry
Barriers To Entry Engineering Resources • Veteran engineering team for product design and development; more than 90 members of the engineering group Greater Access to Materials • Offers broad array of materials to meet customer needs • 50 + years in business and strong supplier relationships • Exclu

Slide 16: National Footprint
National Footprint Gain Efficiencies Asset utilization Sharing best practices Sharing resources 9 Manufacturing Facilities Over 1 million square feet of space

Slide 17: Management Team
R. Jeffrey Bailly – Chairman, CEO & President 31 - year history at the company, beginning as an operations manager in 1988; MBA, CPA. Ronald Lataille – CFO, Sr. VP & Treasurer 21 - year history at the company; CPA. Mitchell Rock – SVP, Sales & Marketing 21 - year history at the company. Chris Litter

Slide 18: Proven Growth Strategy Creating Shareholder Value
Proven Growth Strategy Creating Shareholder Value

Slide 19: Organic Growth Opportunity
Organic Growth (Target of 5% - 7%) • Focus on higher growth markets (Medical – approximately 65% of revenue and growing) • Expand business with existing customers o Offer complementary products and services o Additional value - add services • Gain market share with competitive advantage o Engineerin

Slide 20: Acquisition Growth Opportunity
Acquisition Growth (Target of 5% - 7%) Very fragmented market • No single company controls a large percentage of the market (UFP is one of the largest players) • 500 + companies (potential targets) • Many owner / operators at or near retirement age • Reputation for seamless integration Experienced a

Slide 21: Acquisitive Growth Opportunity
Continue to Focus on Higher - Growth, Higher - Margin Medical Opportunities that Create Value • Become more valuable to our customers • Strategic focus – new capability, geography, market penetration, materials, products • Add scale / market share • Look for synergistic opportunities Goal is for acq

Slide 22: Dielectrics Acquisition
• Revenue $43 million • 100% medical • Single location in Chicopee, Massachusetts • Great cultural and strategic fit • Instantly accretive to earnings • Makes UFP more valuable to medical customers Dielectrics Acquisition

Slide 23: Financial Review
Financial Review Revenue Growth, Margin Expansion & Strong Financial Profile

Slide 24: Financial Targets
10% - 14% Revenue Growth 12% - 14% Operating Margin 27% - 29% 2 Gross Margin 3 to 5 Year Financial Targets Financial Targets

Slide 25: Targeted Revenue Growth
10% to 14% Targeted Revenue Growth Internal Growth + Acquisitions 2 00 1 80 1 60 1 40 1 20 1 00 80 60 40 20 0 2 0 14 2 0 15 2 0 16 2 0 17 2 0 18 2 0 19 $ Millions R e v e nu e

Slide 26: Revenue Mix Shift
1 0 0 , 0 0 0 8 0, 000 6 0, 000 4 0, 000 2 0, 000 0 1 2 0 , 0 0 0 1 4 0 , 0 0 0 M e d i c al Industrial 2 0 14 Consumer 2 0 15 Au t o m o t i v e 2016 Aerospace & Defense 2 0 1 7 2 0 18 E l ec tr o n i cs 2 0 19 Revenue Mix Shift Revenue Mix Shift 2014 to 2019 Medical mix increased from 36% to 65%

Slide 27: Gross Margin Target
Gross Margin Target – 27% to 29% Operating Leverage from Mix Shift + Acquisition synergies + Efficiencies 30.0% 27 - 29%Target 1 0 .0% 1 5 .0% 2 0 .0% 2 5 .0% 2 0 14 2 0 15 2 0 16 2 0 17 2 0 18 2 0 19 Gross Profit Margin

Slide 28: Adjusted Operating Margin Target
Target: 12 - 14% Operating leverage from mix shift + acquisition synergies + efficiencies 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% 2014 2015 2016 2017 2018 2019 Adjusted* Operating Margin

Slide 29: Growing Book Value and EPS
Book Value EPS $1.59 $1.05 $1.05 $1.10 $1.26 $1.93 $2.63 $ 1 0. 00 $ 1 2. 00 $ 1 4. 00 $ 1 6. 00 $ 1 8. 00 $ 2 0. 00 $ 2 4. 00 $ 2 2. 00 2 0 13 2 0 14 2 0 17 2 0 18 2 0 19 2015 BV/ Share 2016 E PS Growing Book Value

Slide 30: Contact
R. Jeffrey Bailly Chairman, CEO & President Newburyport, Massachusetts Ronald Lataille CFO, Sr. VP & Treasurer Newburyport, Massachusetts UFP Technologies 100 Hale St. Newburyport, MA 01950 978 - 352 - 2200 www.ufpt.com

Slide 31: Reconciliation of Non-GAAP Results
Reconciliation of Non - GAAP Results (in Millions) 201 4 201 5 201 6 201 7 2018 201 9 Revenue, As Reported $ 139.3 $ 138.9 $ 146.1 $ 147.8 $ 190.5 $ 198.4 Operating Income, as reported 11.6 11.7 12.2 11.7 19.6 24. 7 Add: Acquisition/ Restructuring related Costs 1. 6 1.8 0.4 0.1 1.1 - Less: Material
Source: SEC EDGAR · 8-K filed Aug 25, 2020
More decks from UFP Technologies, Inc.
Investor Presentation (August 2026)16 slides · Aug 24, 2026
Investor Presentation (August 2026)14 slides · August 2026
Investor Presentation (June 2026)14 slides · Jun 8, 2026
Investor Presentation (June 2026)13 slides · June 2026
Investor Presentation (June 2026)14 slides · June 2026
Q1 2026 Earnings Presentation27 slides · May 5, 2026